Volitionrx (VNRX)
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETos...
- Open
- 0.3460
- High
- 0.3496
- Low
- 0.3300
- Prev. Close
- 0.3499
- Volume
- 1.17M
- Turnover
- 396.76K
- Avg Price
- 0.3381
- Bid/Ask Ratio
- --
- Amplitude
- 5.60%
- 52wk High
- 14.8000
- Volume Ratio
- 4.37
- Turnover Ratio
- 17.06%
Volitionrx Analyst Rating
View moreForecast & Rating
Aug 17, 2026Price forecast
$16.574638.56%
Forecast & RatingBuy
5analysts
- Strong buy60.00%
- Buy20.00%
- Hold20.00%
- Sell0.00%
- Strong sell0.00%
News
- TradingView · 2 hours ago
Fatima Dickey Pushes for Changes at VolitionRx with 7.4% Stake
- PUBT · 2 days ago, 08:46 PM
VolitionRx secures lender waiver for above-cap ATM equity sales under convertible debt deal
- PUBT · 2 days ago, 10:06 AM
VolitionRx issues 4,698,628 shares to Lind Global on note conversions under private placement exemption
- Weekly Review · Aug 29 at 06:34 AM
Weekly Recap | Volitionrx +7.77%, Sysmex deal drives volume spike
- US Stock Market Update · Aug 27 at 11:31 PM
VolitionRx tumbles 9% in after-hours trading after 47% intraday surge
